Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

TELA Bio (TELA) Assets (2018 - 2026)

TELA Bio has reported Assets over the past 8 years, most recently at $81.4 million for Q4 2025.

  • For Q4 2025, Assets fell 5.95% year-over-year to $81.4 million; the TTM value through Dec 2025 reached $81.4 million, down 5.95%, while the annual FY2025 figure was $81.4 million, 5.95% down from the prior year.
  • Assets for Q4 2025 was $81.4 million at TELA Bio, up from $61.6 million in the prior quarter.
  • Over five years, Assets peaked at $94.4 million in Q2 2023 and troughed at $51.3 million in Q2 2022.
  • A 5-year average of $70.8 million and a median of $70.3 million in 2021 define the central range for Assets.
  • Biggest five-year swings in Assets: soared 83.87% in 2023 and later crashed 39.28% in 2024.
  • Year by year, Assets stood at $62.5 million in 2021, then rose by 8.49% to $67.9 million in 2022, then grew by 15.02% to $78.0 million in 2023, then rose by 10.92% to $86.6 million in 2024, then dropped by 5.95% to $81.4 million in 2025.
  • Business Quant data shows Assets for TELA at $81.4 million in Q4 2025, $61.6 million in Q3 2025, and $67.5 million in Q2 2025.